or Try an Advanced Search...

    Monogenic Stocks List

    Symbol Grade Name % Change
    RYTM C Rhythm Pharmaceuticals, Inc. -5.92
    SGMO C Sangamo BioSciences, Inc. -4.65
    TSHA D Taysha Gene Therapies, Inc. -9.25
    VYGR F Voyager Therapeutics, Inc. -9.32
    PASG F Passage Bio, Inc. -12.06
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Gene Therapy Huntington's Disease Life Sciences Lipid Storage Disorders Medicine Monogenic Diseases Organ Systems Rare Diseases Amyotrophic Lateral Sclerosis Ataxia Biopharmaceutical Blastoma Cell Product Central Nervous System Disorders Deficiency Deficiency Syndrome Dow Agrosciences Emerging Technologies Friedreich's Ataxia

    Related ETFs - A few ETFs which own one or more of the above listed Monogenic stocks.

    Symbol Grade Name Weight
    OZEM F Roundhill GLP-1 & Weight Loss ETF 2.38
    BBP C BioShares Biotechnology Products Fund 2.09
    QQQS C Invesco NASDAQ Future Gen 200 ETF 2.05
    IBRN C iShares Neuroscience and Healthcare ETF 1.88
    HAPS B Harbor Corporate Culture Small Cap ETF 1.76
    View all Monogenic ETFs...
    Compare ETFs
    Compare BBP to IBRN Compare IBRN to HAPS Compare OZEM to IBRN

        Monogenic Stocks Recent News

        Date Stock Title
        Nov 15 TSHA Taysha Gene Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Nov 15 SGMO Sangamo Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 14 TSHA Q3 2024 Taysha Gene Therapies Inc Earnings Call
        Nov 14 RYTM Rhythm releases positive Imcivree data for younger age group
        Nov 14 VYGR Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)?
        Nov 14 TSHA Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
        Nov 14 TSHA Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ...
        Nov 14 TSHA Taysha Gene Therapies, Inc. (TSHA) Q3 2024 Earnings Call Transcript
        Nov 13 RYTM Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology
        Nov 13 TSHA Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates
        Nov 13 TSHA Taysha Gene Therapies GAAP EPS of $1.78 beats by $1.87, revenue of $1.78M beats by $0.13M
        Nov 13 TSHA Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
        Nov 13 RYTM Rhythm Pharmaceuticals Announces New Employment Inducement Grants
        Nov 13 SGMO Q3 2024 Sangamo Therapeutics Inc Earnings Call
        Nov 13 VYGR Q3 2024 Voyager Therapeutics Inc Earnings Call
        Nov 13 TSHA Earnings Scheduled For November 13, 2024
        Nov 13 VYGR Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
        Nov 13 SGMO Sangamo Therapeutics Inc (SGMO) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
        Nov 13 VYGR Voyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call Transcript
        Nov 13 SGMO Sangamo Therapeutics, Inc. (SGMO) Q3 2024 Earnings Call Transcript
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Gene Therapy Huntington's Disease Life Sciences Lipid Storage Disorders Medicine Monogenic Diseases Organ Systems Rare Diseases Amyotrophic Lateral Sclerosis Ataxia Biopharmaceutical Blastoma Cell Product Central Nervous System Disorders Deficiency Deficiency Syndrome Dow Agrosciences Emerging Technologies Friedreich's Ataxia
        Monogenic

        Browse All Tags